Cargando…
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden
BACKGROUND: Although evidence suggests a persistently decreased risk of colorectal cancer for up to 10 years among individuals with a negative endoscopic biopsy result (i.e., normal mucosa), concerns have been raised about other long-term health outcomes among these individuals. In this study, we ai...
Autores principales: | Sun, Jiangwei, Fang, Fang, Olén, Ola, Song, Mingyang, Halfvarson, Jonas, Roelstraete, Bjorn, Khalili, Hamed, Ludvigsson, Jonas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949679/ https://www.ncbi.nlm.nih.gov/pubmed/36821532 http://dx.doi.org/10.1371/journal.pmed.1004185 |
Ejemplares similares
-
Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study
por: Sun, Jiangwei, et al.
Publicado: (2022) -
Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study
por: Ludvigsson, Jonas F, et al.
Publicado: (2022) -
Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study
por: Sun, Jiangwei, et al.
Publicado: (2023) -
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden
por: Ludvigsson, Jonas F., et al.
Publicado: (2021) -
Statin use and risk of colorectal cancer in patients with inflammatory bowel disease
por: Sun, Jiangwei, et al.
Publicado: (2023)